全球無針給藥裝置市場規模、佔有率、成長分析，依技術（噴射注射器、經皮貼劑）、最終用戶（醫院和診所到家庭醫療保健機構）- 2024-2031 年行業預測

2022年全球無針給藥裝置市場規模為139.9億美元，預計將從2023年的149.4億美元成長到2031年的252.9億美元，預測期內（2024-2031年）CAGR為6.8% 。

全球無針給藥裝置市場有潛力徹底改變醫療保健產業，標誌著一個重要的成長期。這些設備消除了在給藥過程中使用傳統針頭的情況，從而降低了風險並消除了患者的痛苦。醫療保健產業對無痛給藥方法的需求不斷成長，特別是對於自體免疫疾病和糖尿病等慢性疾病。這種需求，加上對自我注射藥物的需求和不斷增加的老年人口，正在推動市場擴張。經皮貼片和噴射注射器等創新技術已經開發出來，由於其精確性和便利性，為市場成長做出了重大貢獻。醫療機構在採用這些設備方面一直處於領先地位，以優先考慮患者的舒適度和依從性，儘管家庭護理機構也擴大採用這些設備。吸入式藥物輸送系統以及噴射注射器和經皮貼片等新技術正在進入市場，以滿足對患者舒適度和護理的關注所驅動的無針藥物輸送的需求。然而，高開發成本和監管問題等課題可能會阻礙市場成長。全球醫療保健產業的不斷發展確保了無針給藥裝置市場的持續擴張，為提高給藥效率和改善病患照護提供了潛力。

目錄

執行摘要

• 市場概況
• 命運之輪

研究方法論

• 資訊採購
• 二手和主要資料來源
• 市場規模估計
• 市場假設與限制

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題

主要市場洞察

• 技術分析
• 定價分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• 啟動分析
• 原料分析
• 創新矩陣
• 管道產品分析
• 總體經濟指標
• 頂級投資分析
• 成功的關鍵因素
• 競爭程度

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題
• 監管環境
• 波特分析
• 對未來顛覆的特別見解

依技術分類的全球無針給藥裝置市場

• 市場概況
• 噴射器
• 經皮貼劑
• 基於吸入的系統

全球無針給藥裝置市場（依最終用戶）

• 市場概況
• 醫院和診所到家庭醫療機構

全球無針給藥裝置市場規模（依地區）

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • MEA 的其餘部分

競爭格局

• 前 5 名企業比較
• 2021 年關鍵參與者的市場定位
• 主要市場參與者所採取的策略
• 最佳制勝策略
• 近期市集活動
• 主要公司市佔率（%），2021年

主要公司簡介

• Becton, Dickinson and Company (BD) (USA)
• Zogenix (USA)
• Pfizer Inc. (USA)
• Bespak Europe Ltd. (UK, a subsidiary of AptarGroup)
• Janssen Pharmaceuticals (Belgium, subsidiary of Johnson & Johnson)
• PharmaJet (USA)
• 3M (USA)
• National Medical Products Inc. (NMP Pharma) (USA)
• Antares Pharma (USA)
• Crossject (France)
• Novartis AG (Switzerland)
• Bioject Medical Technologies Inc. (USA)
• Pharmajet (USA)
• Astrazeneca (UK)
• Eli Lilly and Company (USA)
• MedImmune (USA, a subsidiary of AstraZeneca)
• Genentech (USA, a subsidiary of Roche)
• Inovio Pharmaceuticals (USA)
• Valeritas (USA)

Global Needle-Free Drug Delivery Devices Market size was valued at USD 13.99 Billion in 2022 and is poised to grow from USD 14.94 Billion in 2023 to USD 25.29 Billion by 2031, at a CAGR of 6.8% during the forecast period (2024-2031).

The global needle-free drug delivery devices market has the potential to revolutionize the healthcare industry, marking a significant period of growth. These devices eliminate the use of traditional needles in administering medication, thereby reducing risks and eliminating patient pain. There is a growing demand in the healthcare sector for pain-free methods of drug administration, especially for chronic conditions like autoimmune disorders and diabetes. This demand, along with the need for self-injected medications and the rising elderly population, is driving market expansion. Innovative technologies such as transdermal patches and jet injectors have been developed, contributing significantly to market growth due to their precision and convenience. Healthcare facilities have been leading in adopting these devices to prioritize patient comfort and compliance, though homecare settings are also increasingly adopting them. New technologies like inhalable drug delivery systems, along with jet injectors and transdermal patches, are entering the market, meeting the demand for needle-free drug delivery driven by a focus on patient comfort and care. However, challenges such as high development costs and regulatory issues could hinder market growth. The ongoing evolution of the global healthcare sector ensures the continued expansion of the needle-free drug delivery devices market, offering the potential to improve drug delivery efficiency and enhance patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Needle-Free Drug Delivery Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Needle-Free Drug Delivery Devices Market Segmental Analysis

Inhalation-based systems, transdermal patches, and jet injector come under the market segment of technology. The major regions in this market are North America, Europe, and Asia-Pacific. The market's end-users include hospitals, clinics, and home healthcare settings.

Drivers of the Global Needle-Free Drug Delivery Devices Market

Technological Advancements: The market has witnessed the introduction of new, highly efficient devices due to continuous enhancements in needle-free drug delivery technology. This progress has enabled the development of advanced tools such as transdermal patches, micro-needles, and jet injectors. These cutting-edge technologies are applicable across various scenarios, with their precision increasing as technology advances.

Enhanced Patient Comfort and Convenience: Unlike traditional injections, which can be painful and carry infection risks, the needle-free drug delivery devices market offers products that are more convenient and less painful. This has led to a significant increase in their usage. Patients with chronic illnesses, who require frequent drug administration, are increasingly preferring these products over conventional methods. As a result, patients are more comfortable continuing their treatments, leading to improved compliance and better treatment outcomes. This improvement in patient care and adherence is a key driver of market growth.

Restraints in the Global Needle-Free Drug Delivery Devices Market

Regulatory Hurdles: The medical device industry, including needle-free drug delivery products, is subject to stringent regulations. The approval process, essential for patient safety and injection effectiveness, can be prolonged and complex. While necessary, these regulations pose challenges. Complying with standards and awaiting approvals can inflate development costs and postpone production and distribution.

Financial Challenges: Needle-free devices can incur significant expenses compared to traditional syringes. These higher costs may impede adoption, particularly in facilities with limited budgets or scarce financial resources. Healthcare centers cannot rely on reimbursement policies to cover the entire cost of these devices, further limiting their accessibility to patients who may benefit from them.

Market Trends of the Global Needle-Free Drug Delivery Devices Market

Expansion of Healthcare Applications: A significant trend observed in the market is the broadening scope of drug delivery devices without needles. These devices are now utilized beyond traditional insulin and vaccine delivery, extending to specialized therapeutics and biologics. Technological advancements have facilitated this expansion into additional applications. With the ongoing need for precise and controlled drug administration, further innovations and applications are anticipated in the market.

Rising Demand for Pain-Free Drug Administration: There is a notable shift away from traditional needle-based injections as consumers increasingly prefer needle-free drug delivery devices. This demand for painless options in drug administration is particularly prevalent among patients with chronic illnesses. This shift has spurred the demand for needle-free tools such as transdermal patches and jet injectors, which can deliver medication directly without causing needle-related pain.

Technological Progress: The needle-free drug delivery industry is experiencing continuous technological innovation, a significant market trend. This ongoing innovation has led to major improvements in product design, enhancing precision and usability to ensure patient compliance. Additionally, advancements have enabled these devices to deliver higher volumes or more viscous medications, making them suitable for a wide range of medications and administration needs.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Needle-free Drug Delivery Devices Market by Technology

• Market Overview
• Jet injectors
• Transdermal patches
• and Inhalation-based systems

Global Needle-free Drug Delivery Devices Market by End-user

• Market Overview
• Hospitals and Clinics to Home Healthcare Settings

Global Needle-free Drug Delivery Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zogenix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bespak Europe Ltd. (UK, a subsidiary of AptarGroup)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Pharmaceuticals (Belgium, subsidiary of Johnson & Johnson)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaJet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• National Medical Products Inc. (NMP Pharma) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antares Pharma (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crossject (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioject Medical Technologies Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmajet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astrazeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedImmune (USA, a subsidiary of AstraZeneca)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (USA, a subsidiary of Roche)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inovio Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeritas (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments